flavonoidrich
extract
paulownia
fortunei
flower
epf
report
prevent
obes
lipid
metabol
diseas
howev
mechan
protect
effect
yet
clear
object
studi
investig
molecular
factor
involv
hypoglycem
hypolipidem
effect
epf
obes
mice
fed
highfat
diet
hfd
male
h
icr
institut
cancer
research
mice
fed
hfd
contain
contain
epf
mgkg
eight
week
epf
reduc
bodi
weight
gain
lipid
accumul
liver
level
lipid
glucos
insulin
plasma
well
reduc
insulin
resist
compar
hfd
group
epf
significantli
decreas
serum
aminotransferas
activ
hfd
group
observ
epf
administr
significantli
increas
level
ampactiv
kinas
ampk
phosphoryl
prevent
fat
deposit
liver
cell
effect
block
compound
c
ampk
inhibitor
protect
effect
epf
probabl
associ
decreas
hmgcr
fa
express
increas
express
result
suggest
epf
might
potenti
natur
candid
treatment
andor
prevent
overweight
hepat
metabolicrel
alter
induc
hfd
nutrient
indigen
medicin
plant
recommend
treatment
mani
metabol
diseas
easi
avail
rel
fewer
side
effect
epidemiolog
studi
reveal
increas
daili
intak
phenol
compound
dietari
supplement
act
antioxid
antiinflammatori
agent
increas
thermogenesi
energi
expenditur
decreas
inflamm
oxid
stress
support
progress
toward
decreas
metabol
disord
previou
studi
confirm
speci
genu
paulownia
belong
famili
scrophulariacea
exhibit
broad
spectrum
biolog
effect
includ
antioxid
anticarcinogen
antiphlogist
antivir
antimicrobi
anticholinesteras
activ
paulownia
fortunei
seem
hemsl
fast
grow
ornament
tree
nativ
mainland
china
distribut
almost
world
speci
renown
polyphenol
rich
plant
use
tradit
chines
medicin
treatment
hypertens
enter
tonsil
bronchiti
dysenteri
flower
p
fortunei
also
use
addit
season
food
china
made
local
delicaci
call
zheng
cai
previou
studi
shown
flower
extract
p
fortunei
epf
contain
high
amount
flavonoid
mainli
compos
apigenin
luteolin
hesperetin
thunberginol
daucosterol
quercetin
kaempferol
deriv
previou
studi
show
flavonoid
puerarin
could
prevent
hyperlipidemia
oxid
stress
lipid
metabol
disord
diseas
liver
reason
hypothes
extract
p
fortunei
flower
epf
might
play
import
role
protect
hfdinduc
hyperlipidemia
insulin
resist
hepat
fat
accumul
studi
first
time
use
highfat
diet
induc
obes
mice
verifi
protect
effect
ethanol
extract
p
fortunei
flower
contain
flavonoid
studi
mechan
focus
effect
enhanc
ampk
signal
pathway
inhibit
lipid
metabol
disord
liver
high
fat
diet
hfd
could
induc
hepat
steatosi
hyperlipidemia
obes
diabet
lipid
metabol
disord
diseas
regul
signal
pathway
lipid
metabol
liver
ampactiv
kinas
ampk
phylogenet
conserv
serinethreonin
protein
kinas
key
regul
energi
metabol
homeostasi
crucial
target
drug
ancient
modern
activ
ampk
play
import
role
regul
energi
balanc
nutrient
metabol
synthesi
fatti
acid
cholesterol
glucos
hepat
gluconeogenesi
translat
moreov
ampk
consid
attract
target
prevent
diseas
obes
diabet
inflamm
cancer
report
ampk
could
activ
natur
phenol
compound
resveratrol
epigallocatechin
gallat
egcg
curcumin
quercetin
caffeic
acid
phenethyl
ester
cape
berberin
theaflavin
flower
p
fortunei
collect
xuzhou
jiangsu
provinc
china
april
eight
kilogram
dri
flower
pulver
powder
extract
three
time
ethanol
l
c
h
filtrat
remov
residu
extract
submit
spraydri
c
inlet
temperatur
c
outlet
temperatur
isol
flavonoid
purifi
sephadex
column
chromatographi
total
flavonoid
content
determin
accord
samad
et
al
follow
colorimetr
method
catechin
use
standard
catechin
concentr
rang
mgml
use
gener
standard
calibr
curv
product
yield
flower
extract
p
fortunei
epf
contain
high
amount
flavonoid
epf
content
mgg
dri
weight
major
flavonoid
determin
high
perform
liquid
chromatographi
hplc
accord
method
describ
slight
modif
tabl
briefli
hplc
analys
perform
agil
seri
liquid
chromatograph
agil
technolog
santa
clara
ca
usa
consist
binari
pump
autosampl
diodearray
detector
dad
zorbax
mm
particl
diamet
agil
technolog
santa
clara
ca
usa
column
employ
gradient
elut
perform
solut
compos
mm
sodium
phosphat
ph
methanol
solut
b
compris
methanol
deliv
flow
rate
mlmin
follow
initi
solut
next
min
anoth
min
anoth
min
anoth
min
final
min
inject
volum
extract
librari
made
compris
retent
time
hplc
spectra
standard
chemic
compound
extract
analyz
use
hplc
system
detect
polyphenol
peak
compar
respect
retent
time
librari
data
express
mean
standard
error
se
n
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
human
hepatocyt
cultur
treat
previous
describ
briefli
human
hepatomaderiv
cell
maintain
low
glucosecontain
dulbecco
modi
eagl
medium
reach
confluenc
cell
serumstarv
h
expos
ffa
free
fatti
acid
induc
fat
overload
cell
treat
epf
gml
ffa
mm
cellular
triglycerid
tg
detect
relat
kit
manufactur
instruct
nanj
jiancheng
bioengin
institut
nanj
china
present
research
report
paper
conduct
accord
chines
legisl
nih
public
use
care
laboratori
anim
relev
univers
committe
anim
experi
approv
experi
ethic
approv
number
male
icr
mice
g
purchas
branch
nation
breeder
center
rodent
beij
china
mice
maintain
environment
control
room
c
humid
week
acclimat
fifti
mice
randomli
assign
five
group
micegroup
group
vehicl
control
mice
fed
standard
normal
chow
diet
snd
consist
kcal
carbohydr
kcal
protein
kcal
fat
total
energi
kcalg
mice
group
ii
group
iii
group
iv
fed
high
fat
diet
hfd
consist
kcal
carbohydr
kcal
protein
kcal
fat
total
energi
kcalg
mice
group
iii
group
iv
fed
high
fat
diet
hfd
daili
given
epf
distil
water
contain
tween
two
dose
mg
kg
day
respect
mice
group
v
epf
mgkg
fed
standard
normal
chow
diet
snd
receiv
epf
distil
water
contain
tween
dose
mg
kg
day
oral
gavag
epf
concentr
set
maximum
concentr
affect
food
intak
preliminari
experi
food
intak
bodi
weight
anim
measur
daili
experi
last
eight
week
end
treatment
mice
sacrif
blood
sampl
drawn
cardiac
punctur
heparin
tube
plasma
separ
centrifug
g
min
c
store
c
analysi
liver
tissu
immedi
excis
experi
store
c
later
use
level
serum
glucos
total
cholesterol
tc
triglycerid
tg
densiti
lipoprotein
ldl
highdens
lipoprotein
hdl
urea
creatinin
activ
alanin
aminotransferas
alt
aspart
aminotransferas
ast
determin
use
commerci
kit
nanj
jiancheng
bioengin
institut
nanj
china
oral
glucos
toler
determin
describ
previous
insulin
level
character
correspond
mous
elisa
kit
accord
manufactur
instruct
insulin
resist
ir
homeostat
index
insulin
resist
homair
determin
describ
previous
kingm
diagnost
gongzhou
china
oil
red
use
stain
intracellular
lipid
describ
previous
briefli
cell
differ
group
cultur
correspond
medium
h
cell
fix
paraformaldehyd
stain
freshli
prepar
work
solut
oil
red
room
temperatur
histolog
chang
liver
evalu
use
commerci
kit
stain
oil
red
solut
nanj
jiangcheng
bioengin
institut
nanj
china
accord
manufactur
protocol
liver
tg
content
determin
describ
previous
level
hepat
tg
extract
solut
determin
enzymat
method
use
commerci
avail
kit
elabsci
biotechnolog
wuhan
hubei
china
accord
instruct
manufactur
measur
effect
epf
gene
express
mous
liver
western
blot
analysi
perform
previous
describ
us
total
protein
content
determin
bca
protein
assay
thermo
scientif
pierc
rockford
il
usa
result
express
mean
standard
error
se
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
anova
p
find
flower
extract
p
fortunei
epf
contain
high
amount
flavonoid
epf
shown
tabl
use
standard
chemic
compound
flavonoid
seven
kind
flavonoid
identifi
extract
p
fortunei
flower
apigenin
luteolin
major
flavonoid
extract
p
fortunei
flower
tabl
show
mice
fed
hfd
gain
bodi
weight
compar
control
group
p
averag
daili
food
intak
per
mous
greater
group
control
group
ii
hfd
group
sinc
calori
densiti
standard
normal
chow
diet
less
high
fat
diet
averag
daili
calori
intak
per
mous
markedli
less
control
group
compar
hfd
group
p
howev
treatment
epf
mgkg
significantli
amelior
hfdinduc
addit
weight
gain
calori
intak
standard
normal
chow
diet
supplement
epf
caus
slight
decreas
bodi
weight
compar
standard
normal
chow
diet
declin
show
signific
differ
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
data
repres
mean
standard
error
se
individu
mice
valu
share
common
superscript
b
c
differ
significantli
p
snd
standard
normal
chow
diet
group
control
low
chow
diet
group
hfd
high
fat
diet
group
hfd
epf
high
fat
diet
extract
p
fortunei
flower
mgkg
determin
whether
epf
attenu
liver
damag
hfd
mice
measur
aminotransferas
activ
shown
tabl
fatrich
diet
led
higher
serum
aminotransferas
activ
alt
ast
compar
control
group
effect
block
epf
supplement
signific
differ
aminotransferas
activ
serum
found
normal
diet
suppli
epf
group
control
group
shown
tabl
hfd
induc
mark
elev
blood
glucos
plasma
insulin
homair
epf
treatment
markedli
lower
fast
plasma
insulin
glucos
homair
rel
hfd
mice
signific
differ
blood
glucos
plasma
insulin
homair
found
normal
diet
suppli
epf
group
control
group
expect
mice
fed
hfd
exhibit
signific
hyperlipidemia
character
increas
tc
tg
ldl
level
serum
compar
control
group
respect
tabl
notabl
epf
treatment
markedli
decreas
serum
tc
tg
ldl
level
hfd
mice
eight
week
p
moreov
hdl
level
significantli
increas
p
group
cotreat
hfd
epf
compar
anim
treat
hfd
p
signific
differ
blood
lipid
level
found
normal
diet
suppli
epf
group
control
group
hfd
group
level
liver
weight
hepat
tg
increas
compar
control
group
respect
p
howev
epf
treatment
reduc
hepat
lipid
accumul
liver
weight
figur
c
signific
differ
liver
tg
content
found
normal
diet
suppli
epf
group
control
group
tissu
section
stain
oil
red
repres
signif
increas
hepat
level
lipid
deposit
hfdfed
mice
compar
control
group
likewis
epf
treatment
attenu
hepat
lipid
accumul
consist
liver
tg
content
figur
ldl
level
hfd
mice
eight
week
p
moreov
hdl
level
significantli
increas
p
group
cotreat
hfd
epf
compar
anim
treat
hfd
p
signific
differ
blood
lipid
level
found
normal
diet
suppli
epf
group
control
group
hfd
group
level
liver
weight
hepat
tg
increas
compar
control
group
respect
p
howev
epf
treatment
reduc
hepat
lipid
accumul
liver
weight
figur
c
signific
differ
liver
tg
content
found
normal
diet
suppli
epf
group
control
group
tissu
section
stain
oil
red
repres
signif
increas
hepat
level
lipid
deposit
hfdfed
mice
compar
control
group
likewis
epf
treatment
attenu
hepat
lipid
accumul
consist
liver
tg
content
figur
reveal
potenti
mechan
epf
action
examin
ampk
phosphoryl
level
liver
hfdfed
mice
figur
show
ampk
phosphoryl
level
significantli
decreas
liver
hfdfed
mice
howev
level
phosphoryl
ampk
reduc
treatment
epf
mgkg
examin
ampk
phosphoryl
level
cell
shown
figur
ampk
phosphoryl
level
continu
increas
h
cell
treat
epf
figur
moreov
cell
treat
epf
h
express
level
phosphoryl
ampk
increas
dosedepend
manner
howev
treatment
compound
c
ampk
inhibitor
phosphoryl
ampk
level
reveal
potenti
mechan
epf
action
examin
ampk
phosphoryl
level
liver
hfdfed
mice
figur
show
ampk
phosphoryl
level
significantli
decreas
liver
hfdfed
mice
howev
level
phosphoryl
ampk
reduc
treatment
epf
mgkg
examin
ampk
phosphoryl
level
cell
shown
figur
ampk
phosphoryl
level
continu
increas
h
cell
treat
epf
figur
moreov
cell
treat
epf
h
express
level
phosphoryl
ampk
increas
dosedepend
manner
howev
treatment
compound
c
ampk
inhibitor
phosphoryl
ampk
level
cell
significantli
reduc
figur
result
clearli
show
epf
treatment
lead
ampk
phosphoryl
nutrient
cell
significantli
reduc
figur
result
clearli
show
epf
treatment
lead
ampk
phosphoryl
examin
effect
ampk
activ
lipid
accumul
ffaexpos
hepatocyt
cell
treat
compound
c
min
prior
epf
treatment
lipid
accumul
cell
measur
h
ffa
exposur
use
oil
red
stain
epf
markedli
inhibit
lipid
accumul
ffaexpos
cell
concentr
cell
significantli
reduc
figur
result
clearli
show
epf
treatment
lead
ampk
phosphoryl
examin
effect
ampk
activ
lipid
accumul
ffaexpos
hepatocyt
cell
treat
compound
c
min
prior
epf
treatment
lipid
accumul
cell
measur
h
ffa
exposur
use
oil
red
stain
epf
markedli
inhibit
lipid
accumul
ffaexpos
cell
concentr
examin
effect
ampk
activ
lipid
accumul
ffaexpos
hepatocyt
cell
treat
compound
c
min
prior
epf
treatment
lipid
accumul
cell
measur
h
ffa
exposur
use
oil
red
stain
epf
markedli
inhibit
lipid
accumul
ffaexpos
cell
concentr
moreov
ffa
exposur
markedli
increas
intracellular
tg
level
cell
compar
control
group
effect
block
compound
c
figur
moreov
ffa
exposur
markedli
increas
intracellular
tg
level
cell
compar
control
group
effect
block
compound
c
figur
investig
mechan
epf
regul
hepat
lipid
accumul
evalu
express
protein
associ
lipid
metabol
liver
shown
figur
express
level
sterol
regulatori
element
bind
protein
reductas
hmgcr
fatti
acid
synthas
fa
markedli
upregul
liver
hfd
group
compar
control
group
howev
epf
supplement
downregul
express
level
protein
target
gene
p
carnitin
palmitoyltransferas
express
level
also
decreas
liver
hfd
group
compar
control
group
interestingli
epf
supplement
significantli
enhanc
express
liver
hfd
group
p
investig
mechan
epf
regul
hepat
lipid
accumul
evalu
express
protein
associ
lipid
metabol
liver
shown
figur
express
level
sterol
regulatori
element
bind
protein
reductas
hmgcr
fatti
acid
synthas
fa
markedli
upregul
liver
hfd
group
compar
control
group
howev
epf
supplement
downregul
express
level
protein
target
gene
p
carnitin
palmitoyltransferas
express
level
also
decreas
liver
hfd
group
compar
control
group
interestingli
epf
supplement
significantli
enhanc
express
liver
hfd
group
p
c
rel
densiti
analysi
hmgcr
rel
densiti
analysi
probe
intern
control
rel
densiti
analysi
vehicl
control
set
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
valu
express
mean
sem
n
valu
share
common
superscript
b
c
differ
significantli
p
activ
insulin
receptor
substrat
play
import
role
blood
glucos
regul
liver
investig
mechan
epf
inhibit
insulin
resist
hfd
group
evalu
ser
phosphoryl
level
mous
liver
shown
figur
ser
phosphoryl
level
markedli
increas
liver
hfd
group
compar
control
group
interestingli
epf
supplement
significantli
enhanc
tyr
phosphoryl
liver
hfdfed
mice
p
c
rel
densiti
analysi
hmgcr
rel
densiti
analysi
probe
intern
control
rel
densiti
analysi
vehicl
control
set
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
valu
express
mean
sem
n
valu
share
common
superscript
b
c
differ
significantli
p
activ
insulin
receptor
substrat
play
import
role
blood
glucos
regul
liver
investig
mechan
epf
inhibit
insulin
resist
hfd
group
evalu
ser
phosphoryl
level
mous
liver
shown
figur
ser
phosphoryl
level
markedli
increas
liver
hfd
group
compar
control
group
interestingli
epf
supplement
significantli
enhanc
tyr
phosphoryl
liver
hfdfed
mice
p
western
blot
analysi
phosphoryl
level
liver
mice
rel
densiti
express
ratio
vehicl
control
set
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
valu
express
mean
sem
n
valu
share
common
superscript
b
c
differ
significantli
p
flower
p
fortunei
long
use
medicin
food
sourc
china
howev
detail
inform
relat
benefici
effect
polyphenol
composit
remain
scarc
aim
evalu
protect
effect
extract
p
fortunei
flower
epf
insulin
resist
lipid
metabol
disord
liver
found
flower
extract
p
fortunei
epf
contain
high
amount
flavonoid
current
studi
clearli
indic
epf
inhibit
hyperlipidemia
hepat
lipid
accumul
insulin
resist
obes
mice
ampk
pathway
sever
studi
reveal
high
fat
diet
could
caus
hepat
steatosi
hyperlipidemia
hyperinsulinemia
obes
insulin
resist
lipid
metabol
disord
diseas
human
laboratori
anim
result
present
studi
show
highfat
diet
led
signific
increas
bodi
weight
hyperlipidemia
hyperglycemia
hyperinsulinemia
hepat
lipid
accumul
agreement
previou
studi
phenol
compound
widespread
plant
show
therapeut
effect
obes
hfdinduc
diseas
studi
shown
tabl
observ
supplement
epf
mgkg
significantli
deceas
bodi
weight
compar
hfd
mice
respect
suggest
epf
antiobes
effect
high
fat
diet
could
induc
liver
damag
previou
research
found
flower
extract
scrophulariacea
famili
plant
protect
effect
hepatotox
consist
found
epf
supplement
significantli
decreas
diagnost
indic
liver
damag
compar
fatrich
diet
tabl
result
suggest
suscept
epf
harm
action
fatrich
diet
protect
effect
epf
well
known
longterm
hfd
could
induc
hyperglycemia
elev
blood
insulin
level
moreov
increas
insulin
secret
part
relat
pancreat
islet
hyperplasia
progress
insulinresist
hfd
suppli
present
studi
found
blood
glucos
insulin
level
homair
increas
significantli
p
hfd
group
compar
control
group
reveal
insulin
resist
hfd
group
tabl
furthermor
rise
blood
glucos
level
may
attribut
larg
accumul
fat
liver
enhanc
gluconeogenesi
induc
hepat
cell
reduc
transform
figur
western
blot
analysi
phosphoryl
level
liver
mice
rel
densiti
express
ratio
vehicl
control
set
signific
differ
among
group
assess
oneway
anova
tukey
post
hoc
test
valu
express
mean
sem
n
valu
share
common
superscript
b
c
differ
significantli
p
flower
p
fortunei
long
use
medicin
food
sourc
china
howev
detail
inform
relat
benefici
effect
polyphenol
composit
remain
scarc
aim
evalu
protect
effect
extract
p
fortunei
flower
epf
insulin
resist
lipid
metabol
disord
liver
found
flower
extract
p
fortunei
epf
contain
high
amount
flavonoid
current
studi
clearli
indic
epf
inhibit
hyperlipidemia
hepat
lipid
accumul
insulin
resist
obes
mice
ampk
pathway
sever
studi
reveal
high
fat
diet
could
caus
hepat
steatosi
hyperlipidemia
hyperinsulinemia
obes
insulin
resist
lipid
metabol
disord
diseas
human
laboratori
anim
result
present
studi
show
highfat
diet
led
signific
increas
bodi
weight
hyperlipidemia
hyperglycemia
hyperinsulinemia
hepat
lipid
accumul
agreement
previou
studi
phenol
compound
widespread
plant
show
therapeut
effect
obes
hfdinduc
diseas
studi
shown
tabl
observ
supplement
epf
mgkg
significantli
deceas
bodi
weight
compar
hfd
mice
respect
suggest
epf
antiobes
effect
high
fat
diet
could
induc
liver
damag
previou
research
found
flower
extract
scrophulariacea
famili
plant
protect
effect
hepatotox
consist
found
epf
supplement
significantli
decreas
diagnost
indic
liver
damag
compar
fatrich
diet
tabl
result
suggest
suscept
epf
harm
action
fatrich
diet
protect
effect
epf
well
known
longterm
hfd
could
induc
hyperglycemia
elev
blood
insulin
level
moreov
increas
insulin
secret
part
relat
pancreat
islet
hyperplasia
progress
insulinresist
hfd
suppli
present
studi
found
blood
glucos
insulin
level
homair
increas
significantli
p
hfd
group
compar
control
group
reveal
insulin
resist
hfd
group
tabl
furthermor
rise
blood
glucos
level
may
attribut
larg
accumul
fat
liver
enhanc
gluconeogenesi
induc
hepat
cell
reduc
transform
glucos
fat
caus
lipodystrophi
howev
epf
supplement
hfdinduc
obes
mice
eight
week
markedli
amelior
insulin
resist
condit
indic
lower
serum
glucos
insulin
level
end
experi
compar
hfd
group
thought
stimul
pancreat
insulin
secret
cell
islet
langerhan
aldos
reductas
enzym
inhibitori
activ
rich
flavonoid
apigenin
luteolin
rutin
hesperetin
epf
might
play
import
role
antiobes
hypoglycem
effect
decreas
insulin
level
mice
suppli
epf
may
attribut
reduc
bodi
weight
gain
fat
accumul
liver
moreov
protect
effect
epf
obes
lipid
accumul
could
also
attribut
prevent
hyperlipidemia
hyperglycemia
mice
fed
hfd
thu
epf
could
inhibit
insulinresist
conduc
classic
diabet
mellitu
treatment
previou
research
laboratori
other
illustr
sever
flavonoid
includ
puerarin
quercetin
hesperetin
epicatechin
apigenin
anthocyanin
could
reduc
serum
lipid
level
previou
report
reveal
differ
result
regard
chang
serum
tg
tc
ldlc
level
icr
mice
treat
hfd
eight
week
present
observ
agreement
previou
demonstr
hfd
increas
level
tg
tc
ldlc
interestingli
epf
treatment
markedli
decreas
serum
tc
tg
ldl
level
increas
hdl
level
hfd
mice
eight
week
suggest
flavonoid
might
main
bioactiv
compound
epf
exhibit
benefici
effect
lipid
profil
tabl
furthermor
digest
intestin
absorpt
flavonoid
apigenin
luteolin
quercetin
hesperetin
epf
might
lower
hepat
lipid
accumul
suppress
hepat
lipogenesi
lipid
absorpt
observ
epf
treatment
significantli
decreas
liver
weight
liver
triglycerid
content
mice
dosedepend
manner
histolog
analysi
show
epf
supplement
markedli
reduc
lipid
vacuol
lipid
droplet
liver
hfdfed
mice
figur
consist
liver
tg
content
ampk
play
import
role
regul
energi
statu
lipid
metabol
also
potenti
therapeut
target
mani
preval
diseas
includ
diabet
obes
high
blood
pressur
mani
studi
show
sever
natur
compound
includ
resveratrol
epigallocatechin
gallat
berberin
quercetin
could
inhibit
lipidrel
metabol
disord
regul
ampk
activit
target
gene
studi
epf
markedli
stimul
ampk
activ
liver
mice
cell
figur
result
suggest
ampk
pathway
may
involv
modul
hepat
lipid
metabol
liver
hfdfed
mice
cell
treat
epf
consist
regul
ampk
inhibitor
compound
c
block
effect
epf
lipid
accumul
cell
demonstr
ampk
activ
necessari
modul
hepat
lipid
metabol
figur
ampk
mediat
lipid
metabol
liver
regul
express
level
target
gene
fa
acc
hmgcr
previou
report
show
ampk
coordin
longterm
adapt
lipid
metabol
regul
transcript
factor
key
transcript
factor
involv
control
cholesterol
fatti
acid
synthesi
increas
transcript
fa
result
increas
synthesi
tg
sever
studi
demonstr
flavonoid
extract
plant
could
inhibit
lipidrel
metabol
disord
regul
express
level
ampk
target
gene
demonstr
western
blot
analysi
epf
supplement
significantli
downregul
express
level
ampk
target
gene
hmgcr
endoplasm
reticulum
bound
peroxisom
enzym
ratelimit
step
cholesterol
biosynthesi
suggest
epf
posit
effect
due
lower
express
hmgcr
contribut
inhibit
serum
cholesterol
increas
due
high
fat
diet
figur
moreov
epf
treatment
significantli
downregul
express
level
fa
key
enzym
involv
lipogenesi
upregul
express
level
carnitin
palmitoil
transferas
catalyz
entranc
fatti
acid
mitochondria
rate
limit
enzym
hepat
fatti
acid
figur
therefor
result
impli
reduc
biosynthesi
enhanc
fatti
acid
oxid
might
contribut
benefici
effect
epf
hyperlipidemia
hepat
lipid
accumul
hfd
mice
data
explain
antiobes
hypolipidem
hypoglycem
effect
epf
certain
extent
previous
express
insulin
resist
anoth
key
pathophysiolog
featur
pathogenesi
high
fat
diet
mice
hyperlipidemia
hyperglycemia
induc
high
fat
diet
could
decreas
number
insulin
receptor
glucos
transport
metabol
therebi
increas
insulin
resist
reduc
insulin
sensit
insulin
signal
cascad
event
initi
activ
insulin
receptor
substrat
ir
ampk
could
regul
glucos
metabol
insulin
resist
ir
pathway
insulin
resist
could
also
decreas
ampk
phosphoryl
increas
express
level
suppress
activ
inhibit
insulin
signal
therebi
decreas
glucos
uptak
util
understand
molecular
mechan
contribut
insulin
resist
observ
effect
epf
supplement
key
factor
insulin
signal
liver
tissu
figur
consist
report
result
show
hfd
feed
week
increas
express
level
inhibit
downstream
molecul
ser
phosphoryl
substanti
develop
insulin
resist
liver
mice
howev
epf
dietari
supplement
partial
complet
prevent
alter
associ
hfd
consumpt
suggest
epf
might
natur
flavonoidrich
extract
activ
turn
regul
express
downstream
gene
involv
hepat
glucos
lipid
metabol
lower
blood
glucos
lipid
first
report
extract
p
fortunei
flower
potent
protect
effect
hyperlipidemia
hepat
lipid
accumul
insulin
resist
hfd
mice
protect
effect
epf
least
part
associ
decreas
lipogenesi
increas
glucos
metabol
induc
fatti
acid
oxid
liver
ampk
pathway
propos
possibl
protect
effect
epf
figur
result
emphas
import
dietari
intervent
treatment
andor
prevent
diseas
induc
hfd
although
seven
flavonoid
compound
identifi
extract
p
fortunei
flower
hplc
analysi
clear
bioactiv
agent
therefor
question
warrant
investig
nutrient
biosynthesi
enhanc
fatti
acid
oxid
might
contribut
benefici
effect
epf
hyperlipidemia
hepat
lipid
accumul
hfd
mice
data
explain
antiobes
hypolipidem
hypoglycem
effect
epf
certain
extent
previous
express
insulin
resist
anoth
key
pathophysiolog
featur
pathogenesi
high
fat
diet
mice
hyperlipidemia
hyperglycemia
induc
high
fat
diet
could
decreas
number
insulin
receptor
glucos
transport
metabol
therebi
increas
insulin
resist
reduc
insulin
sensit
insulin
signal
cascad
event
initi
activ
insulin
receptor
substrat
ir
ampk
could
regul
glucos
metabol
insulin
resist
ir
pathway
insulin
resist
could
also
decreas
ampk
phosphoryl
increas
express
level
suppress
activ
inhibit
insulin
signal
therebi
decreas
glucos
uptak
util
understand
molecular
mechan
contribut
insulin
resist
observ
effect
epf
supplement
key
factor
insulin
signal
liver
tissu
figur
consist
report
result
show
hfd
feed
week
increas
express
level
inhibit
downstream
molecul
ser
phosphoryl
substanti
develop
insulin
resist
liver
mice
howev
epf
dietari
supplement
partial
complet
prevent
alter
associ
hfd
consumpt
suggest
epf
might
natur
flavonoidrich
extract
activ
turn
regul
express
downstream
gene
involv
hepat
glucos
lipid
metabol
lower
blood
glucos
lipid
first
report
extract
p
fortunei
flower
potent
protect
effect
hyperlipidemia
hepat
lipid
accumul
insulin
resist
hfd
mice
protect
effect
epf
least
part
associ
decreas
lipogenesi
increas
glucos
metabol
induc
fatti
acid
oxid
liver
ampk
pathway
propos
possibl
protect
effect
epf
figur
result
emphas
import
dietari
intervent
treatment
andor
prevent
diseas
induc
hfd
although
seven
flavonoid
compound
identifi
extract
p
fortunei
flower
hplc
analysi
clear
bioactiv
agent
therefor
question
warrant
investig
biosynthesi
enhanc
fatti
acid
oxid
might
contribut
benefici
effect
epf
hyperlipidemia
hepat
lipid
accumul
hfd
mice
data
explain
antiobes
hypolipidem
hypoglycem
effect
epf
certain
extent
previous
express
insulin
resist
anoth
key
pathophysiolog
featur
pathogenesi
high
fat
diet
mice
hyperlipidemia
hyperglycemia
induc
high
fat
diet
could
decreas
number
insulin
receptor
glucos
transport
metabol
therebi
increas
insulin
resist
reduc
insulin
sensit
insulin
signal
cascad
event
initi
activ
insulin
receptor
substrat
ir
ampk
could
regul
glucos
metabol
insulin
resist
ir
pathway
insulin
resist
could
also
decreas
ampk
phosphoryl
increas
express
level
suppress
activ
inhibit
insulin
signal
therebi
decreas
glucos
uptak
util
understand
molecular
mechan
contribut
insulin
resist
observ
effect
epf
supplement
key
factor
insulin
signal
liver
tissu
figur
consist
report
result
show
hfd
feed
week
increas
express
level
inhibit
downstream
molecul
ser
phosphoryl
substanti
develop
insulin
resist
liver
mice
howev
epf
dietari
supplement
partial
complet
prevent
alter
associ
hfd
consumpt
suggest
epf
might
natur
flavonoidrich
extract
activ
turn
regul
express
downstream
gene
involv
hepat
glucos
lipid
metabol
lower
blood
glucos
lipid
first
report
extract
p
fortunei
flower
potent
protect
effect
hyperlipidemia
hepat
lipid
accumul
insulin
resist
hfd
mice
protect
effect
epf
least
part
associ
decreas
lipogenesi
increas
glucos
metabol
induc
fatti
acid
oxid
liver
ampk
pathway
propos
possibl
protect
effect
epf
figur
result
emphas
import
dietari
intervent
treatment
andor
prevent
diseas
induc
hfd
although
seven
flavonoid
compound
identifi
extract
p
fortunei
flower
hplc
analysi
clear
bioactiv
agent
therefor
question
warrant
investig
